Risk factor
Strong & resilient to price shocks
Profitability factor
Strong margins and returns
About
Max Healthcare Institute Limited serves as a leading provider of healthcare services across India. The company offers a comprehensive range of medical specialties, including advanced fields such as oncology, cardiac sciences, neurosciences, liver and kidney transplantation, orthopedics, nephrology, bone marrow transplantation, bariatric and weight loss surgery, minimally invasive/laparoscopic procedures, urology, gastroenterology, and aesthetic and reconstructive surgery. Beyond its core hospital services, Max Healthcare extends its offerings through Max@Home, which delivers health and wellness solutions directly to patients' residences, and MaxLab, providing diagnostic testing to individuals outside its hospital network via third-party laboratory management. As of August 27, 2021, its extensive infrastructure comprised 17 healthcare facilities. This network includes tertiary and quaternary care hospitals strategically located in Delhi NCR (Saket, Patparganj, Vaishali, Rajendra Place, Shalimar Bagh), Mumbai, Mohali, Bathinda, and Dehradun. A secondary care hospital operates in Gurugram, complemented by day care centers in Noida, Lajpat Nagar, and Panchsheel Park within the Delhi NCR, along with another in Mohali, Punjab. Max Healthcare Institute Limited maintains its corporate headquarters in Gurugram, India.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EB
Target Price
The average target price of MAXHEALTH.NS is 1072 and suggests 6% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommen